CN104940131B - 一种盐酸千金藤碱水针剂及其制备方法 - Google Patents
一种盐酸千金藤碱水针剂及其制备方法 Download PDFInfo
- Publication number
- CN104940131B CN104940131B CN201510298482.8A CN201510298482A CN104940131B CN 104940131 B CN104940131 B CN 104940131B CN 201510298482 A CN201510298482 A CN 201510298482A CN 104940131 B CN104940131 B CN 104940131B
- Authority
- CN
- China
- Prior art keywords
- injection
- liquid drugs
- cepharantin hydrochloride
- drugs injection
- cepharantin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 title claims abstract description 97
- 238000002347 injection Methods 0.000 title claims abstract description 83
- 239000007924 injection Substances 0.000 title claims abstract description 83
- VQAWRQZAAIQXHM-UHFFFAOYSA-N Cepharanthine Natural products O1C(C=C2)=CC=C2CC(C=23)N(C)CCC3=CC=3OCOC=3C=2OC(=CC=23)C(OC)=CC=2CCN(C)C3CC2=CC=C(O)C1=C2 VQAWRQZAAIQXHM-UHFFFAOYSA-N 0.000 title claims abstract description 81
- YVPXVXANRNDGTA-WDYNHAJCSA-N cepharanthine Chemical compound C1C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@H](C2=C3)N(C)CCC2=CC(OC)=C3OC2=C(OCO3)C3=CC3=C2[C@H]1N(C)CC3 YVPXVXANRNDGTA-WDYNHAJCSA-N 0.000 title claims abstract description 81
- 239000003814 drug Substances 0.000 title claims abstract description 64
- 229940079593 drug Drugs 0.000 title claims abstract description 63
- 239000007788 liquid Substances 0.000 title claims abstract description 62
- 238000002360 preparation method Methods 0.000 title claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 30
- 239000008215 water for injection Substances 0.000 claims abstract description 20
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 36
- 239000011780 sodium chloride Substances 0.000 claims description 16
- 238000003756 stirring Methods 0.000 claims description 16
- 238000001914 filtration Methods 0.000 claims description 12
- 230000001954 sterilising effect Effects 0.000 claims description 11
- 238000010521 absorption reaction Methods 0.000 claims description 10
- 238000009835 boiling Methods 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical group [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 5
- 239000003002 pH adjusting agent Substances 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 238000005516 engineering process Methods 0.000 abstract description 3
- 230000000052 comparative effect Effects 0.000 description 19
- 239000003643 water by type Substances 0.000 description 14
- 241000345998 Calamus manan Species 0.000 description 8
- 239000000546 pharmaceutical excipient Substances 0.000 description 8
- 235000012950 rattan cane Nutrition 0.000 description 8
- 239000003513 alkali Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000007789 sealing Methods 0.000 description 4
- UEAPAHNNFSZHMW-UHFFFAOYSA-N stepahnine Natural products COC1=CC=CC(C2=C34)=C1CC3N(C)CCC4=CC1=C2OCO1 UEAPAHNNFSZHMW-UHFFFAOYSA-N 0.000 description 4
- UEAPAHNNFSZHMW-CQSZACIVSA-N stephanine Chemical compound CN([C@@H]1CC2=C(C3=C11)C=CC=C2OC)CCC1=CC1=C3OCO1 UEAPAHNNFSZHMW-CQSZACIVSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 3
- 238000013112 stability test Methods 0.000 description 3
- 239000013505 freshwater Substances 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000008354 sodium chloride injection Substances 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- BJWWOUUGCAPHOV-UHFFFAOYSA-N 1,3-dibenzylisoquinoline Chemical class C=1C2=CC=CC=C2C(CC=2C=CC=CC=2)=NC=1CC1=CC=CC=C1 BJWWOUUGCAPHOV-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
样品 | 0月 | 6月 | 12月 | 18月 | 24个月 |
实施例一 | 100.2 | 100.0 | 99.5 | 99.0 | 98.1 |
实施例三 | 99.9 | 99.9 | 99.7 | 99.3 | 98.7 |
实施例四 | 100.1 | 100.0 | 99.7 | 99.2 | 98.6 |
对比例一 | 99.8 | 99.2 | 95.4 | 88.7 | 80.5 |
对比例二 | 100.0 | 99.4 | 96.7 | 89.6 | 82.0 |
对比例三 | 100.1 | 99.2 | 94.0 | 87.5 | 79.4 |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510298482.8A CN104940131B (zh) | 2015-06-03 | 2015-06-03 | 一种盐酸千金藤碱水针剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510298482.8A CN104940131B (zh) | 2015-06-03 | 2015-06-03 | 一种盐酸千金藤碱水针剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104940131A CN104940131A (zh) | 2015-09-30 |
CN104940131B true CN104940131B (zh) | 2017-12-12 |
Family
ID=54155573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510298482.8A Active CN104940131B (zh) | 2015-06-03 | 2015-06-03 | 一种盐酸千金藤碱水针剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104940131B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102475680A (zh) * | 2010-11-24 | 2012-05-30 | 菏泽步长制药有限公司 | 一种盐酸千金藤素注射剂及其制法和检测方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101507725A (zh) * | 2008-12-31 | 2009-08-19 | 河南省医药科学研究院 | 千金藤碱及其盐酸盐在制备抗乙肝病毒药物中的应用 |
-
2015
- 2015-06-03 CN CN201510298482.8A patent/CN104940131B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102475680A (zh) * | 2010-11-24 | 2012-05-30 | 菏泽步长制药有限公司 | 一种盐酸千金藤素注射剂及其制法和检测方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104940131A (zh) | 2015-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104013571A (zh) | 一种奥硝唑注射液及其制备方法 | |
CN106822175A (zh) | 一种碳酸氢钠林格注射液及其制备方法 | |
CN106692124A (zh) | 乙酰半胱氨酸药物组合物及其制备方法 | |
CN102626409B (zh) | 一种含18种氨基酸的药物组合物 | |
CN104840418B (zh) | 一种盐酸法舒地尔注射液组合物及其制备方法 | |
CN104644551B (zh) | 一种供注射用的含有盐酸法舒地尔的药物组合物 | |
CN104940131B (zh) | 一种盐酸千金藤碱水针剂及其制备方法 | |
CN102872462B (zh) | 一种盐酸氨溴索组合物及其制剂 | |
CN102716076A (zh) | 一种供注射用的盐酸氨溴索药物组合物 | |
WO2020248648A1 (zh) | 一种奥硝唑注射液和s-奥硝唑注射液 | |
CN103690479B (zh) | 一种格隆溴铵注射液及其制备方法 | |
CN103238586B (zh) | 一种心肌脏器保存液制备方法 | |
CN105640935A (zh) | 供注射用甲磺酸艾日布林药物组合物 | |
CN102525893B (zh) | 盐酸去氧肾上腺素注射液及其制剂工艺 | |
CN101791315A (zh) | 复方甘草酸单铵s药物组合物及其大容量注射剂制备方法 | |
CN101264054A (zh) | 利福霉素钠注射液及其制备方法 | |
CN107281096A (zh) | 一种含帕拉米韦的水针剂及其制备方法 | |
CN104337760B (zh) | 一种二盐酸组胺注射液及其制备方法 | |
CN104161756B (zh) | 一种盐酸奥普力农注射液组合物 | |
CN103239392B (zh) | 一种奥硝唑注射制剂及制备方法 | |
CN102204908B (zh) | 一种含依达拉奉化合物的药物组合物及其制备方法 | |
CN107281097A (zh) | 一种含沙芬酰胺的水针剂及其制备方法 | |
CN109529016B (zh) | 一种胞磷胆碱钠注射液及其制备方法 | |
CN102600143B (zh) | 长春西汀药物组合物及其制备方法 | |
CN105726475A (zh) | 一种治疗晚期卵巢癌的注射液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20151119 Address after: 510520, Guangzhou, Guangdong province Tianhe District hi tech Road, No. 32, No. 34, block B1, South Building, 4 floor, East Applicant after: GUANGZHOU SALIAI STEMCELL SCIENCE AND TECHNOLOGY Co.,Ltd. Address before: South 5 building 510632 Guangdong city of Guangzhou province Tianhe District Whampoa Road West, No. 601 Jinan University College of life science and technology Applicant before: Guangzhou Jinan Biomedical Research and Development center |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 510032 -29, No. 339 Heng Jiang Road, Conghua suburb street, Guangzhou, Guangdong (first floor, A factory). Patentee after: GUANGZHOU SALIAI STEMCELL SCIENCE AND TECHNOLOGY Co.,Ltd. Address before: 510520 east 4 floor, B1 south tower, 32 and 34, Tianhe District high tech Road, Guangzhou, Guangdong. Patentee before: GUANGZHOU SALIAI STEMCELL SCIENCE AND TECHNOLOGY Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 510320 unit 403a, 4th floor, production area, No. 1, helix 4th Road, International Biological Island, Huangpu District, Guangzhou, Guangdong Province Patentee after: Guangzhou kangqilai precision medical technology Co.,Ltd. Address before: 510032 -29, No. 339 Heng Jiang Road, Conghua suburb street, Guangzhou, Guangdong (first floor, A factory). Patentee before: GUANGZHOU SALIAI STEMCELL SCIENCE AND TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220726 Address after: 510610 room 4105, No. 365, Tianhe North Road, Tianhe District, Guangzhou, Guangdong Province (office only) Patentee after: Guangzhou Shaobo Holding Group Co.,Ltd. Address before: 510320 unit 403a, 4th floor, production area, No. 1, helix 4th Road, International Biological Island, Huangpu District, Guangzhou, Guangdong Province Patentee before: Guangzhou kangqilai precision medical technology Co.,Ltd. |